Citations

Clear

653 citation(s) found for "Kantarci, Kejal".

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2
Jack, Clifford R. , Barnes, Josephine , Bernstein, Matt A. , Borowski, Bret, Brewer, James, Clegg, Shona , Dale, Anders M. , Carmichael, Owen , Ching, Christopher R. K. , DeCarli, Charles , Desikan, Rahul S. , Fennema‐Notestine, Christine , Fjell, Anders M. , Fox, Nick C. , Gunter, Jeff, Holland, Dominic , Hua, Xue , Kantarci, Kejal , Krueger, Gunnar, Leung, Kelvin K., Mackin, Scott, Maillard, Pauline , Malone, Ian B. , Mattsson, Niklas , McEvoy, Linda K. , Modat, Marc , Mueller, Susanne G. , Nosheny, Rachel L. , Ourselin, Sébastien , Schuff, Norbert, Senjem, Matthew L. , Simonson, Alix, Thompson, Paul M. , Rettmann, Dan , Vemuri, Prashanthi , Walhovd, Kristine B. , Zhao, Yansong , Zuk, Samantha M., Weiner, Michael W. , DeCarli, Charles , Borowski, Bret J, Zuk, Samantha, Fletcher, Evan M. , Gutman, Boris A , Insel, Philip S. , Killiany, Ronald , Bernstein, Matt A , Jack, Clifford R , Vemuri, Prashanthi , Dale, Anders M , Thompson, Paul M , Senjem, Matthew L , Ching, Christopher R K , Kantarci, Kejal , Fox, Nick C , Maillard, Pauline

Mayo Clinic

Alzheimer's & Dementia | July 17, 2015 | Volume: 11 | Issue: 7 | Pages: 740-756

10.1016/j.jalz.2015.05.002 | PMID 26194310 Get It

AbstractIntroductionAlzheimer's Disease Neuroimaging Initiative (ADNI) is now in its 10th year. The primary objective of the magnetic resonance imaging (MRI) core of ADNI has been to improve methods for clinical trials in Alzheimer's disease (AD) and related disorders.MethodsWe review the contributions of the MRI core from present and past cycles of ADNI (ADNI‐1, ‐Grand Opportunity and ‐2). We also review plans for the future‐ADNI‐3.ResultsContributions of the MRI core include creating standardized acquisition protocols and quality control methods; examining the effect of technical features of image acquisition and analysis on outcome metrics; deriving sample size estimates for future trials based on those outcomes; and piloting the potential utility of MR perfusion, diffusion, and functional connectivity measures in multicenter clinical trials.DiscussionOver the past decade the MRI core of ADNI has fulfilled its mandate of improving methods for clinical trials in AD and will continue to do so in the future.
Vascular Imaging Abnormalities and Cognition
Griswold, Michael , Lirette, Seth T. , Kantarci, Kejal , Sharrett, A. Richey , Graff‐Radford, Jonathan , Schneider, Andrea L.C. , Windham, B. Gwen , Coker, Laura H., Albert, Marilyn , Wruck, Lisa , Knopman, David S. , Gottesman, Rebecca F. , Jack, Clifford R. , Mosley, Thomas H. , Kantarci, Kejal , Lirette, Seth , Schneider, Andrea L C , Wruck, Lisa M

Mayo Clinic

Stroke | January 7, 2015 | Volume: 46 | Issue: 2 | Pages: 433-440

10.1161/strokeaha.114.007847 | PMID 25563642 Get It

Background and Purpose— The relationships between cerebrovascular lesions visible on imaging and cognition are complex. We explored the possibility that the cerebral cortical volume mediated these relationships. Methods— Total of 1906 nondemented participants (59% women; 25% African–American; mean age, 76.6 years) in the Atherosclerosis Risk in Communities (ARIC) study underwent cognitive assessments, risk factor assessments, and quantitative MRI for white matter hyperintensities (WMH) and infarcts. The Freesurfer imaging analysis pipeline was used to determine regional cerebral volumes. We examined the associations of cognitive domain outcomes with cerebral volumes (hippocampus and separate groups of posterior and frontal cortical regions of interest) and cerebrovascular imaging features (presence of large or small cortical/subcortical infarcts and WMH volume). We performed mediation pathway analyses to assess the hypothesis that hippocampal and cortical volumes mediated the associations between cerebrovascular imaging features and cognition. Results— In unmediated analyses, WMH and infarcts were both associated with worse psychomotor speed/executive function. In mediation analyses, WMH and infarct associations on psychomotor speed/executive function were significantly attenuated, but not abolished, by the inclusion of the posterior cortical regions of interest volume in the models, and the infarcts on psychomotor speed/executive function association were attenuated, but not abolished, by inclusion of the frontal cortical regions of interest volume. Conclusions— Both WMH and infarcts were associated with cortical volume, and both lesions were also associated with cognitive performance, implying shared pathophysiological mechanisms. Although cross-sectional, our findings suggest that WMH and infarcts could be proxies for clinically covert processes that directly damage cortical regions. Microinfarcts are 1 candidate for such a clinically covert process.
Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging
Weigand, Stephen D. , Wiste, Heather J. , Vemuri, Prashanthi , Knopman, Davis S., Lowe, Val J. , Roberts, Rosebud O., Kantarci, Kejal , Rocca, Walter A. , Petersen, Ronald C. , Mielke, Michelle M. , Machulda, Mary M. , Jack, Clifford R. , Vemuri, Prashanthi , Kantarci, Kejal

Mayo Clinic

Alzheimer's & Dementia | November 15, 2014 | Volume: 10 | Issue: 6 | Pages: 779-789

10.1016/j.jalz.2014.09.001 | PMID 25458308 Get It

AbstractBackgroundInexpensive, non‐invasive tools for assessing Alzheimer‐type pathophysiologies are needed. Computerized cognitive assessments are prime candidates.MethodsCognitively normal participants, aged 51–71, with magnetic resonance imaging, fluorodeoxyglucose‐positron emission tomography (FDG‐PET), amyloid PET, CogState computerized cognitive assessment, and standard neuropsychological tests were included. We first examined the association between the CogState battery and neuroimaging measures. We then compared that association to the one between standard neuropsychological z‐scores and neuroimaging.ResultsSlower reaction times for CogState Identification and One Back, and lower memory and attention z‐scores, were associated (P < .05) with FDG‐PET hypometabolism. Slower time on the Groton Maze Learning Task and worse One Card Learning accuracy were associated (P < .05) with smaller hippocampal volumes. There were no associations with amyloid PET. Associations of CogState and neuropsychological Z‐scores with neuroimaging were small and of a similar magnitude.ConclusionsCogState subtests were cross‐sectionally comparable to standard neuropsychological tests in their relatively weak associations with neurodegeneration imaging markers.
Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult
Raman, Mekala R., Wiste, Heather J. , Senjem, Matthew L. , Ward, Chadwick P., Kantarci, Kejal , Jack, Clifford R. , Senjem, Matthew L , Kantarci, Kejal

Mayo Clinic

Neurology | November 3, 2014 | Volume: 83 | Issue: 19 | Pages: 1771-1772

10.1212/wnl.0000000000000957 | PMID 25367059 Get It

IC‐02‐06: LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOLOGICAL MEASURES IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT
Weigand, Stephen D. , Przybelski, Scott A. , Graff‐Radford, Jonathan , Mathew, Senjem, Gunter, Jeffrey L. , Whitwell, Jennifer , Graff‐Radford, Neill R. , Josephs, Kieth, Fields, Julie A. , Lucas, John A. , Lowe, Val J. , Gavrilova, Ralitza, Kuntz, Karen M. , Hernandez, Mariely DeJesus, Rademakers, Rosa , Petersen, Ronald C. , Jones, David T. , Knopman, David S. , Wszołek, Zbigniew K. , Vemuri, Prashanthi , Machulda, Mary M. , Ferman, Tanis J. , Baker, Matthew , Kantarci, Kejal , Jack, Clifford R. , Boeve, Bradley F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2014.04.029 Get It

IC‐P‐062: DATSCAN FINDINGS IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER AND/OR COGNITIVE IMPAIRMENT
Lowe, Val J. , Graff‐Radford, Jonathan, Peller, Patrick J., Silber, Michael H. , Bennett, Jamie, Aakre, Jeremiah A. , Knopman, David S. , Petersen, Ronald C. , Boeve, Bradley F. , Kantarci, Kejal , Graff‐Radford, Jonathan , Jones, David T. , Mielke, Michelle M. , Ferman, Tanis J. , Louis, Erik K. St. , Smith, Glenn E. , Pankratz, V. Shane , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2014.05.067 Get It

O1‐12‐03: THAL AMYLOID PHASE: CLINICOPATHOLOGIC AND PIB‐PET IMPLICATIONS OF AD PATHOPHYSIOLOGY
Murray, Melissa E. , Graff‐Radford, Neill R. , Liesinger, Amanda M., Rawal, Bhupendra, Petersen, Ronald C. , Duara, Ranjan , Lowe, Val J. , Cannon, Ashley , Jack, Clifford R. , Kantarci, Kejal , Ross, Owen A. , Duara, Ranjan , Dickson, Dennis W. , Murray, Melissa E

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2014.04.124 Get It